Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.
Sign Up to like & getrecommendations! Published in 2017 at "Vaccine"
DOI: 10.1016/j.vaccine.2016.11.063
Abstract: An important focus in vaccine research is the design of vaccine vectors with low seroprevalence and high immunogenicity. Replication-incompetent lymphocytic choriomeningitis virus (rLCMV) vectors do not elicit vector-neutralizing antibody responses, and homologous prime-boost regimens with… read more here.
Keywords: choriomeningitis virus; siv; vectors expressing; vaccine ... See more keywords